AbCellera Biologics Inc.ABCLNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank86
3Y CAGR+76.1%
5Y CAGR-39.0%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
+76.1%/yr
Annual compound
5Y CAGR
-39.0%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
2025160.56%
2024-24.17%
2023-92.17%
202229.38%
202160.92%
20201907.88%
201931.49%
20180.00%